Gujarat Inject (Kerala) Ltd

Fri 23/10/2026,16:1:0 | BSE : GUJINJEC

₹9.900.11 (1.12%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 9.80

Previous Close

₹ 9.79

Volume

231147

Mkt Cap ( ₹ Cr)

₹ 145.03

High

₹ 9.90

Low

₹ 9.78

52 Week High

₹ 14.30

52 Week Low

₹ 2.04

Book Value Per Share

₹ 0.80

Dividend Yield

₹ 0.00

Face Value

₹₹1.00

What's Your Call?

Collective community sentiment on Gujarat Inject (Kerala) Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Gujarat Inject (Kerala) Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Gujarat Inject - Board Meeting Intimation for Issue Of Shares Via Preferential Issue

    22 Oct 2026, 9:48AM Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to conside
  • Gujarat Inject has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    22 Oct 2026, 7:00AM As of September 2026, 100.00% owned by Public. <p align=justify>
  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    15 Oct 2026, 5:28PM Media Release on Purchase Order.
  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    15 Oct 2026, 10:24AM Purchase order of Total Value of Rs.6.25 Crore.
  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    5 Oct 2026, 3:25PM Press Release/Media Release
  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    3 Oct 2026, 8:38PM We would like to inform you that the GUJARAT INJECT KERALA LIMITED has received a purchase order from ZENTARAA INFRA PROJECTS PRIVATE LIMITED 3600Nos
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 7:36PM Scrutnizer Report And Voting Result of 35th Annual General Meeting
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 7:36PM Scrutnizer Report And Voting Result of 35th Annual General Meeting
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 7:36PM Scrutnizer Report And Voting Result of 35th Annual General Meeting
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 7:36PM Scrutnizer Report And Voting Result of 35th Annual General Meeting
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 7:36PM Scrutnizer Report And Voting Result of 35th Annual General Meeting
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Outcome of AGM

    29 Sep 2026, 7:17PM Proceeding of 35th Annual General Meting held on 29th September, 2026
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 7:36PM Scrutnizer Report And Voting Result of 35th Annual General Meeting
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 7:36PM Scrutnizer Report And Voting Result of 35th Annual General Meeting
  • Gujarat Inject - Intimation To Shareholders Regarding Sub-Division / Split Of Equity Shares From Face Value Of ?10/- Each To

    25 Sep 2026, 11:52AM Intimation to shareholders regarding action requires to initiate the process of claiming of shares in demate accounts.
  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    7 Sep 2026, 8:56PM Appointment of Statutory Auditor of the company subject to approval of members of the company.
  • Gujarat Inject - Reg. 34 (1) Annual Report.

    7 Sep 2026, 8:52PM Annual Report for FY 2025-26
  • Gujarat Inject - Shareholder Meeting - AGM On 29Th September, 2026

    7 Sep 2026, 8:48PM AGM Schedule to be held on 29th September, 2026.
  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 Aug 2026, 8:17AM Press note/Media Released Q2 2026-2027
  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    24 Aug 2026, 12:46PM Announcement regarding enter into Strategic Business Partnership Agreement
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    21 Aug 2026, 9:36PM Voting Results along with Scrutinizer's Report.
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Outcome of EGM

    19 Aug 2026, 9:33PM Proceedings of Adjourned 01/2026-27 Extra Ordinary General Meeting held on Wednesday, 19th August, 2026 at 03:30 PM.
  • Gujarat Inject - Shareholder Meeting / Postal Ballot-Outcome of EGM

    12 Aug 2026, 6:23PM EGM Adjourned due to lack of requisite quorum. The company is process to send notice to held the Adjourned EGM.
  • Gujarat Inject - Announcement under Regulation 30 (LODR)-Change in Management

    10 Aug 2026, 6:47PM Appointment of Chief Financial Officer of the Company with effect from 10th August, 2026.

Key fundamentals

Evaluate the intrinsic value of Gujarat Inject (Kerala) Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 11.8298 10.0124 8.5453 -0.2298 -0.1441
Liabilities 11.8298 10.0124 8.5453 -0.2298 -0.1441
Equity 14.6348 14.6348 11.2923 4.8848 4.8848
Gross Profit 2.308 1.0751 0.0448 -0.3771 -0.0452
Net Profit 1.8141 1.0171 0.0827 0.041 0.0022
Cash From Operating Activities 21.2201 -1.5465 -6.0276 0.0526 -0.0002
NPM(%) 4.99 5.34 1.42 23.59 9.77
Revenue 36.3204 19.0457 5.7883 0.1738 0.0226
Expenses 34.0124 17.9706 5.7434 0.5509 0.0678
ROE(%) 15.31 8.58 0.69 0.34 0.01

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Gujarat Inject (Kerala) Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 756.00 -3.22 19.31 5.59 -26.19 0.65
Lotus Eye Hospital and Institute Ltd 112.80 1.58 1605.71 20.36 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 9.29 1.20 0.00 42.27 -39.50 0.00
Astec Lifesciences Ltd 664.30 -1.23 0.00 21.81 -363.14 0.00

Company Info

Gujarat Inject (Kerala) Limited (GIKL) was incorporated on 7th January, 1991 and obtained Certificate for Commencement of Business on 14th February, 1991. The Company has been jointly promoted by the Kerala State Industrial Development Corporation Limited(KSIDC), a wholly owned subsidiary of Government of Kerala Undertaking and Gujarat Inject Limited (GIL) and its associates. GIL is a profit making dividend paying company. The Company has received SIA Registration to manufacture intravenous solutions at Puddussey East, Kanjikode, in Palghat District in Kerala. b) MAIN OBJECTS OF THE COMPANY The main object of the Company as set out fully in the Memorandum of Association of the Company are to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation,intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits. The immediate object of the Company is to set up a project for manufacture of intravenous (IV) Fluids solutions in aspectic bottles. Gujarat Inject (Kerala) Limited (GIKL) is promoted in the joint sector by Gujarat Inject Limited (GIL), Baroda and its associates along with the Kerala State Industrial Development Corporation Limited (KSIDC) a wholly owned subsidiary of the Government of Kerala.

Gujarat Inject (Kerala) Limited (GIKL) was incorporated on 7th January, 1991 and obtained Certificate for Commencement of Business on 14th February, 1991. The Company has been jointly promoted by the Kerala State Industrial Development Corporation Limited(KSIDC), a wholly owned subsidiary of Government of Kerala Undertaking and Gujarat Inject Limited (GIL) and its associates. GIL is a profit making dividend paying company. The Company has received SIA Registration to manufacture intravenous solutions at Puddussey East, Kanjikode, in Palghat District in Kerala. b) MAIN OBJECTS OF THE COMPANY The main object of the Company as set out fully in the Memorandum of Association of the Company are to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation,intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits. The immediate object of the Company is to set up a project for manufacture of intravenous (IV) Fluids solutions in aspectic bottles. Gujarat Inject (Kerala) Limited (GIKL) is promoted in the joint sector by Gujarat Inject Limited (GIL), Baroda and its associates along with the Kerala State Industrial Development Corporation Limited (KSIDC) a wholly owned subsidiary of the Government of Kerala.

Parent Organisation

Gujarat Inject (Kerala) Ltd.

Founded

07/01/1991

Managing Director

Mr.Murli Nair

NSE Symbol

FAQ